The ABSA International Emerging Infectious Diseases Committee (EIDC) continues to update the toolboxes for salient infectious diseases and other relevant topics such as antimicrobial resistance. The latest updates include the following:
SARS-CoV-2/COVID-19 Toolbox updates feature resources related to minimizing transmission of SARS CoV-2 from free-range animals to humans, recent peer-reviewed publications on SARS CoV-2 variants, transition from pandemic to endemic status of SARS CoV-2 transmission, COVID-19-related syndromes, CDC updates regarding isolation and quarantine timing. Lastly, the EIDC’s resource titled Considerations for Handling Potential SARS-CoV-2 samples was updated to reflect the recent Federal Select Agent and Toxins Interim Rule published in 2021 which added SARS-CoV-2 chimeric viruses to the list of HHS Select Agents.
Influenza Toolbox updates include resources on surveillance, impact of the SARS-CoV-2 transmission on influenza virus transmission and vaccine development.
Viral Hemorrhagic Fever Viruses Toolbox includes updated resources for Ebola Virus and African Swine Fever Virus.
The Zika Virus Toolbox includes recent resources related to transmission and vaccines.
Lastly, the Antibiotic/Antimicrobial Resistance Toolbox contains available resources from the USA and European authorities.
We look forward to receiving feedback from ABSA International members on how to improve these resources. Please send your questions, comments, and suggestions to info@absa.org.
